{
    "id": "New-v26-1772080084512-5195",
    "stem": "The nurse is caring for a patient with end-stage renal disease (ESRD) who is receiving hemodialysis three times a week. After today's dialysis session, the patient reports feeling lightheaded and weak. Which of the following nursing actions is MOST appropriate?",
    "type": "trend",
    "scoring": {
        "method": "dichotomous",
        "maxPoints": 1
    },
    "pedagogy": {
        "cjmmStep": "analyzeCues",
        "topicTags": [
            "General"
        ],
        "bloomLevel": "apply",
        "difficulty": 3,
        "nclexCategory": "Physiological Adaptation"
    },
    "rationale": {
        "correct": "Place the patient in a supine position and elevate the legs. This increases venous return to the heart, which can help to raise blood pressure and alleviate lightheadedness.",
        "mnemonic": {
            "acronym": "ELEVATE",
            "meaning": "Elevate Legs, Evaluate Vitals, Listen to Heart and Lungs, Ensure Safety, Treat Underlying Cause, Educate Patient"
        },
        "incorrect": "Administer a bolus of intravenous (IV) fluids to correct the hypotension. While IV fluids might be necessary, it's crucial to first attempt less invasive measures like positioning. Rapid fluid administration can also lead to fluid overload in ESRD patients.",
        "questionTrap": {
            "commonMistake": "Many students may be tempted to administer IV fluids immediately, but non-invasive interventions should always be attempted first unless the patient is severely hypotensive or unresponsive.",
            "whyTheyFallForIt": "Students may prioritize immediate correction of the hypotension without considering the potential risks of fluid overload in an ESRD patient."
        },
        "clinicalPearls": [
            "Post-dialysis hypotension is a common complication of hemodialysis.",
            "Non-pharmacological interventions, such as positioning, are often the first line of treatment for mild to moderate hypotension.",
            "Careful monitoring of vital signs and fluid status is essential in patients receiving hemodialysis.",
            "Always consider the patient's underlying medical conditions and medications when managing post-dialysis complications."
        ]
    },
    "itemContext": {
        "sbar": "15:00, Situation: 68-year-old male with ESRD, post-hemodialysis. Chief complaint: lightheadedness and weakness. Background: ESRD secondary to diabetic nephropathy, hemodialysis 3x/week. Assessment: BP 90/60 mmHg, HR 110 bpm, alert and oriented but weak. Recommendation: Place patient supine with legs elevated. Reassess BP and HR in 5 minutes. Consider further intervention based on response. Monitor for fluid overload.",
        "tabs": [
            {
                "id": "sbar",
                "title": "SBAR",
                "content": "15:00, Situation: 68-year-old male with ESRD, post-hemodialysis. Chief complaint: lightheadedness and weakness. Background: ESRD secondary to diabetic nephropathy, hemodialysis 3x/week. Assessment: BP 90/60 mmHg, HR 110 bpm, alert and oriented but weak. Recommendation: Place patient supine with legs elevated. Reassess BP and HR in 5 minutes. Consider further intervention based on response. Monitor for fluid overload."
            },
            {
                "id": "vitals",
                "title": "Vitals",
                "content": "BP: 90/60 mmHg, HR: 110 bpm, RR: 18, SpO2: 96% on room air, Temperature: 37.0°C (98.6°F)"
            },
            {
                "id": "labs",
                "title": "Labs",
                "content": "Potassium: 5.8 mEq/L, Hemoglobin: 9.5 g/dL, Creatinine: 8.0 mg/dL, BUN: 80 mg/dL, Sodium: 138 mEq/L"
            },
            {
                "id": "radiology",
                "title": "Radiology",
                "content": "Chest X-ray: No acute cardiopulmonary findings."
            },
            {
                "id": "mar",
                "title": "MAR",
                "content": "Epoetin alfa 4000 units subcutaneously weekly, Calcium acetate 667 mg PO TID with meals, Sevelamer 800 mg PO TID with meals, Lisinopril 10 mg PO daily, Atorvastatin 20 mg PO daily"
            }
        ],
        "patient": {
            "age": 68,
            "pmh": "End-Stage Renal Disease (ESRD) secondary to diabetic nephropathy, Hypertension, Hyperlipidemia",
            "gender": "Male",
            "allergies": "NKDA",
            "currentMedications": "Epoetin alfa, Calcium acetate, Sevelamer, Lisinopril, Atorvastatin"
        }
    },
    "sentinelStatus": "deep_healed_v2026"
}